WEC
MRNA icon

Winslow Evans & Crocker’s Moderna MRNA Stock Holding History

Winslow Evans & Crocker’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.11M Sell
10,667
-3,260
-23% -$330K 0.21% 113
2020
Q3 		$985K Sell
13,927
-2,125
-13% -$148K 0.24% 96
2020
Q2 		$1.03M Sell
16,052
-934
-5% -$51.1K 0.28% 81
2020
Q1 		$510K Buy
16,986
+3,500
+26% +$80.5K 0.17% 127
2019
Q4 		$266K Buy
13,486
+850
+7% +$15.1K 0.07% 248
2019
Q3 		$202K Buy
12,636
+386
+3% +$5.7K 0.06% 281
2019
Q2 		$182K Hold
12,250
– – 0.05% 298
2019
Q1 		$252K Buy
+12,250
New +$227K 0.07% 265

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Winslow Evans & Crocker's MRNA Position: Q4 2020 in Review

Winslow Evans & Crocker reduced its Moderna (MRNA) stake by 23% in Q4 2020, selling an estimated $330K and leaving 10,667 shares worth $1.11M. The position accounts for 0.21% of the portfolio, ranked #113.

Winslow Evans & Crocker first reported a position in MRNA in Q1 2019 and has held it in 8 quarters since. 717 funds tracked by Wall St. Rank hold MRNA as of Q4 2020.

  • Winslow Evans & Crocker held 10,667 shares of Moderna worth $1.11M as of Q4 2020.
  • Winslow Evans & Crocker sold 3,260 Moderna shares in Q4 2020, an estimated $330K.
  • Moderna made up 0.21% of Winslow Evans & Crocker's portfolio in Q4 2020, its #113 holding.
  • Winslow Evans & Crocker first reported a position in Moderna in Q1 2019 and has held it in 8 quarters since.
  • 717 funds tracked by Wall St. Rank held Moderna as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.